(Q47849953)

6 February 2018

review article

1 reference

title

Efficacy of interferon monotherapy in the treatment of relapsers and nonresponders with chronic hepatitis C infection (English)

1 reference

6 February 2018

1 reference

Brass CA

1

1 reference

6 February 2018

publication date

1 May 1998

1 reference

6 February 2018

published in

Clinical Therapeutics

1 reference

6 February 2018

volume

20

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

388-397

1 reference

6 February 2018

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980050-7

7 January 2021

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980050-7

7 January 2021

Therapy of hepatitis C: re-treatment with alpha interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980050-7

7 January 2021

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980050-7

7 January 2021

Long-term interferon alfa-2b retreatment of relapsing patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980050-7

7 January 2021

Retreatment with interferon-alpha of chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980050-7

7 January 2021

Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980050-7

7 January 2021

Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980050-7

7 January 2021

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980050-7

7 January 2021

10.1016/S0149-2918(98)80050-7

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018